AntalGenics is a biotechnology company that develops active molecules for biomedical and dermatological applications.
AntalGenics has raised $917K in total funding. The most recent round was Undisclosed. The last funding was announced in February 2022.
AntalGenics's investors include Inveready, Centre for the Development of Industrial Technology (CDTI).
AntalGenics is headquartered in Alicante, Spain.
AntalGenics is a biotechnology company that develops active molecules for biomedical and dermatological applications.
AntalGenics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AntalGenics — Funding & Investors." VCBacked, February 11, 2022, https://www.vcbacked.co/company/antalgenics. Accessed November 14, 2026.
VCBacked. (2022). AntalGenics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/antalgenics
{{cite web |title=AntalGenics — Funding & Investors |url=https://www.vcbacked.co/company/antalgenics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at AntalGenics? Request a listing update